In a landmark study in 1998, a genetically engineered mouse featuring targeted disruption of the gelatinase B (GB; MMP-9; 92 kD gelatinase) gene was used to explore the immunopathogenesis of pemphigoid [42]. The gene discussed is MMP9; the disease is autoimmune bullous skin disease.